The NCE Research division of Piramal Enterprises focuses on the discovery and development of innovative small molecule medicines to improve the lives of patients suffering from cancer and metabolic disorders.
The key elements of our strategy include capitalizing on Piramal’s strengths, in particular the India advantage, and leveraging external partnerships to achieve high levels of R&D productivity. Piramal’s state-of-the-art Research Centre in Mumbai has comprehensive capabilities spanning target identification all the way through clinical development.
Awards and Acievements
Piramal Life Sciences – NCE Research has won the prestigious Organization of Pharmaceutical Producers of India (OPPI) award for the fifth time.